Wednesday, January 18, 2017 4:29:02 PM
Abattis Bioceuticals Corp (TSE:ATT) insider Rene David acquired 200,000 shares of the stock in a transaction on Thursday, January 12th. The shares were purchased at an average price of C$0.09 per share, for a total transaction of C$18,000.00.
https://www.thecerbatgem.com/2017/01/18/abattis-bioceuticals-corp-att-insider-rene-david-acquires-200000-shares.html
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM